Registry study of nonalcoholic steatohepatitis
Not Applicable
Recruiting
- Conditions
- on-alcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000049068
- Lead Sponsor
- Japan Agency for Medical Research and Development (AMED)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with alcoholic liver disease with a daily alcohol consumption of more than 80 g, Patients with specific liver diseases, such as autoimmune hepatitis, primary cholestatic cholangitis, Wilson's disease, Budd-Chiari syndrome, haemochromatosis, etc.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie NASH progression in the JPRN-UMIN000049068 registry study?
How do AMED's NASH registry findings compare to standard-of-care treatment outcomes in Japan?
What biomarkers are associated with fibrosis stages in histologically confirmed NASH patients?
Are there novel therapeutic targets identified in the JPRN-UMIN000049068 nonalcoholic steatohepatitis cohort?
What adverse events are reported in Japanese NASH registries and how are they managed?